FindTrial
Sign In

Effect of etanercept BS1 on physical function of elderly patients with rheumatoid arthritis in daily clinical practice(STEP1)

Effect of etanercept BS1 on physical function of elderly patients with rheumatoid arthritis in daily clinical practice(STEP1) - Happiness

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000037798
Enrollment
50
Registered
2019-09-01
Start date
2019-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Interventions

None listed

Sponsors

Happiness study Group
Lead Sponsor
Katayama Orthopedic Rheumatology Clinic Komagamine Orthopedic and Rheumatology Clinic Mitsuka Rheumatology Clinic Maki Tanaka Orthopedic Clinic Miyake Orthopedic Clinic Matsubara Mayflower Hospital Matsubara Clinic Sakaisakihana Hospital Hara Hospital Yoshii Hospital Kondo Clinic for Rheumatology and Orthopaedics Center for Arthritis and Clinical Rheumatology, Matsubara Clinic Department of Drug Policy and Management, Graduate School of Pharmaceutical Sciences, The University of Toky
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients over 65 years old diagnosed with rheumatoid arthritis Patients starting etanercept BS1 treatment

Exclusion criteria

Exclusion criteria: Patients who received biological or JAK inhibitors before study

Design outcomes

Primary

MeasureTime frame
Changes in Locomo 25 and EQ5D-5L after 26 and 52 weeks from the start of treatment.—

Secondary

MeasureTime frame
Onset of adversed events Disease activety score based 28 joints Simplified disease activity index—

Countries

Japan

Contacts

Public ContactKeiko Funahashi

research Institute of Joint Desease Vice president

kansetsusaisei123@cup.ocn.ne.jp078-230-1233

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026